Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Treatment as prevention and cure towards global eradication of hepatitis C virus.

Hagan LM, Wolpe PR, Schinazi RF.

Trends Microbiol. 2013 Dec;21(12):625-33. doi: 10.1016/j.tim.2013.09.008. Epub 2013 Nov 14. Review.

PMID:
24238778
[PubMed - indexed for MEDLINE]
2.

Clinical relevance of HCV antiviral drug resistance.

Welsch C, Zeuzem S.

Curr Opin Virol. 2012 Oct;2(5):651-5. doi: 10.1016/j.coviro.2012.08.008. Epub 2012 Sep 21. Review.

PMID:
23006585
[PubMed - indexed for MEDLINE]
3.

New hepatitis C therapies: the toolbox, strategies, and challenges.

Pawlotsky JM.

Gastroenterology. 2014 May;146(5):1176-92. doi: 10.1053/j.gastro.2014.03.003. Epub 2014 Mar 12. Review.

PMID:
24631495
[PubMed - indexed for MEDLINE]
4.

Can hepatitis C virus infection be eradicated in people who inject drugs?

Grebely J, Dore GJ.

Antiviral Res. 2014 Apr;104:62-72. doi: 10.1016/j.antiviral.2014.01.002. Epub 2014 Jan 24. Review.

PMID:
24468275
[PubMed - indexed for MEDLINE]
5.

Recent advances in antiviral agents: antiviral drug discovery for hepatitis viruses.

Tanikawa K.

Curr Pharm Des. 2006;12(11):1371-7. Review.

PMID:
16611121
[PubMed - indexed for MEDLINE]
6.

Burden of pediatric hepatitis C.

El-Shabrawi MH, Kamal NM.

World J Gastroenterol. 2013 Nov 28;19(44):7880-8. doi: 10.3748/wjg.v19.i44.7880. Review.

PMID:
24307782
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Hepatitis C virus entry.

Zeisel MB, Felmlee DJ, Baumert TF.

Curr Top Microbiol Immunol. 2013;369:87-112. doi: 10.1007/978-3-642-27340-7_4. Review.

PMID:
23463198
[PubMed - indexed for MEDLINE]
8.

Direct-acting and host-targeting HCV inhibitors: current and future directions.

Chatel-Chaix L, Germain MA, Götte M, Lamarre D.

Curr Opin Virol. 2012 Oct;2(5):588-98. doi: 10.1016/j.coviro.2012.08.002. Epub 2012 Sep 5. Review.

PMID:
22959589
[PubMed - indexed for MEDLINE]
9.

Emerging antiviral drugs for hepatitis C virus.

Enomoto M, Tamori A, Kawada N.

Rev Recent Clin Trials. 2009 Sep;4(3):179-84. Review.

PMID:
20028330
[PubMed - indexed for MEDLINE]
10.

Antiviral treatment of hepatitis C virus infection and factors affecting efficacy.

Zhu Y, Chen S.

World J Gastroenterol. 2013 Dec 21;19(47):8963-73. doi: 10.3748/wjg.v19.i47.8963. Review.

PMID:
24379621
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The era of direct-acting antivirals has begun: the beginning of the end for HCV?

Vachon ML, Dieterich DT.

Semin Liver Dis. 2011 Nov;31(4):399-409. doi: 10.1055/s-0031-1297928. Epub 2011 Dec 21. Review.

PMID:
22189979
[PubMed - indexed for MEDLINE]
12.

A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.

Suzuki T.

Jpn J Infect Dis. 2010 Sep;63(5):307-11. Review.

PMID:
20858994
[PubMed - indexed for MEDLINE]
Free Article
13.

Challenges and successes in developing new therapies for hepatitis C.

De Francesco R, Migliaccio G.

Nature. 2005 Aug 18;436(7053):953-60. Review.

PMID:
16107835
[PubMed - indexed for MEDLINE]
14.

New targets for treatment against HCV infection.

Pan Q, van der Laan LJ.

Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):505-15. doi: 10.1016/j.bpg.2012.10.002. Review.

PMID:
23199508
[PubMed - indexed for MEDLINE]
15.

Viral response to specifically targeted antiviral therapy for hepatitis C and the implications for treatment success.

Cooper C.

Can J Gastroenterol. 2010 Jun;24(6):385-90. Review.

PMID:
20559582
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements.

Grebely J, Matthews GV, Lloyd AR, Dore GJ.

Clin Infect Dis. 2013 Oct;57(7):1014-20. doi: 10.1093/cid/cit377. Epub 2013 May 31.

PMID:
23728143
[PubMed - indexed for MEDLINE]
Free Article
17.

Profile of alisporivir and its potential in the treatment of hepatitis C.

Gallay PA, Lin K.

Drug Des Devel Ther. 2013;7:105-15. doi: 10.2147/DDDT.S30946. Epub 2013 Feb 15. Review.

PMID:
23440335
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Hepatitis C viral kinetics: the past, present, and future.

Chatterjee A, Smith PF, Perelson AS.

Clin Liver Dis. 2013 Feb;17(1):13-26. doi: 10.1016/j.cld.2012.09.003. Review.

PMID:
23177280
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection.

Adiwijaya BS, Kieffer TL, Henshaw J, Eisenhauer K, Kimko H, Alam JJ, Kauffman RS, Garg V.

PLoS Comput Biol. 2012 Jan;8(1):e1002339. doi: 10.1371/journal.pcbi.1002339. Epub 2012 Jan 5.

PMID:
22241977
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Hepatitis C virus-specific directly acting antiviral drugs.

Delang L, Neyts J, Vliegen I, Abrignani S, Neddermann P, De Francesco R.

Curr Top Microbiol Immunol. 2013;369:289-320. doi: 10.1007/978-3-642-27340-7_12. Review.

PMID:
23463206
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk